<DOC>
	<DOC>NCT02780388</DOC>
	<brief_summary>The purpose of this study is to determine whether MEDI4920 is safe and tolerable in patients with adult-onset rheumatoid arthritis.</brief_summary>
	<brief_title>A Phase 1b Study of MEDI4920 in Subjects With Adult-onset Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<criteria>adultonset rheumatoid arthritis swollen and tender joints venous thromboembolism or arterial thrombosis pregnant or breastfeeding hepatitis B, C or HIV active or untreated latent tuberculosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>MEDI4920, CD40L, RA, rheumatoid arthritis</keyword>
</DOC>